Anadys Pharmaceuticals Stock Price, News & Analysis (NASDAQ:ANDS)

Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Anadys Pharmaceuticals (NASDAQ:ANDS)

Anadys Pharmaceuticals, Inc. is a biopharmaceutical company engaged in developing medicines for the treatment of hepatitis C. The Company is focusing on the development of ANA598, a direct-acting antiviral (DAA) for the treatment of hepatitis C. It also focuses to resume the clinical development of ANA773, an oral, small-molecule inducer of endogenous interferons that acts via the Toll-like receptor 7, or TLR7, pathway for the treatment of hepatitis C. In January 2011, the Company initiated a Phase IIb clinical study of ANA598 in combination with SOC for the treatment of hepatitis C. In the Phase IIb study, approximately 200 chronically infected genotype 1 hepatitis C patients are to receive ANA598 200 mg bid in combination with standard of care (SOC), with a loading dose of 800 mg ANA598 bid on day one. In addition, approximately 66 chronically infected genotype 1 hepatitis C patients are to receive placebo added to SOC.

Receive ANDS News and Ratings via Email

Sign-up to receive the latest news and ratings for ANDS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Bio Therapeutic Drugs
Sub-IndustryN/A
SectorHealthcare
SymbolNASDAQ:ANDS
CUSIPN/A
Phone+1-858-5303600

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A

Anadys Pharmaceuticals (NASDAQ:ANDS) Frequently Asked Questions

What is Anadys Pharmaceuticals' stock symbol?

Anadys Pharmaceuticals trades on the NASDAQ under the ticker symbol "ANDS."

Who are some of Anadys Pharmaceuticals' key competitors?

How do I buy Anadys Pharmaceuticals stock?

Shares of Anadys Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Anadys Pharmaceuticals?

Anadys Pharmaceuticals' mailing address is Suite 200, 5871 Oberlin Drive, SAN DIEGO, CA 92121, United States. The biopharmaceutical company can be reached via phone at +1-858-5303600.


MarketBeat Community Rating for Anadys Pharmaceuticals (ANDS)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  27 (Vote Outperform)
Underperform Votes:  38 (Vote Underperform)
Total Votes:  65
MarketBeat's community ratings are surveys of what our community members think about Anadys Pharmaceuticals and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Anadys Pharmaceuticals (NASDAQ:ANDS) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Anadys Pharmaceuticals (NASDAQ:ANDS) Earnings History and Estimates Chart

Earnings by Quarter for Anadys Pharmaceuticals (NASDAQ:ANDS)

Anadys Pharmaceuticals (NASDAQ ANDS) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/7/2011($0.14)($0.15)ViewN/AView Earnings Details
8/8/2011($0.12)($0.14)ViewN/AView Earnings Details
5/5/2011($0.10)($0.10)ViewN/AView Earnings Details
3/3/2011($0.09)($0.04)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Anadys Pharmaceuticals (NASDAQ:ANDS) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Anadys Pharmaceuticals (NASDAQ:ANDS)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Anadys Pharmaceuticals (NASDAQ ANDS)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

Anadys Pharmaceuticals (NASDAQ ANDS) News Headlines

Source:
No headlines for this company have been tracked by MarketBeat.com

SEC Filings

Anadys Pharmaceuticals (NASDAQ:ANDS) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Anadys Pharmaceuticals (NASDAQ:ANDS) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Anadys Pharmaceuticals (NASDAQ ANDS) Stock Chart for Wednesday, December, 13, 2017

Loading chart…

This page was last updated on 12/13/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.